Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Arpin is critical for phagocytosis in macrophages and is targeted by human rhinovirus.

Jubrail J, Africano-Gomez K, Herit F, Mularski A, Bourdoncle P, Oberg L, Israelsson E, Burgel PR, Mayer G, Cunoosamy DM, Kurian N, Niedergang F.

EMBO Rep. 2020 Jan 7;21(1):e47963. doi: 10.15252/embr.201947963. Epub 2019 Nov 13.

PMID:
31721415
2.

Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices.

Zemanick E, Burgel PR, Taccetti G, Holmes A, Ratjen F, Byrnes CA, Waters VJ, Bell SC, VanDevanter DR, Stuart Elborn J, Flume PA; Antimicrobial Resistance International Working Group in Cystic Fibrosis.

J Cyst Fibros. 2019 Oct 31. pii: S1569-1993(19)30919-1. doi: 10.1016/j.jcf.2019.10.006. [Epub ahead of print]

PMID:
31680041
3.

Validation of Short- and Long-term Demographic Forecasts Using the Canadian Cystic Fibrosis Registry.

Martelli V, Sykes J, Burgel PR, Bellis G, Coriati A, Stanojevic S, Stephenson AL.

Eur Respir J. 2019 Oct 24. pii: 1901667. doi: 10.1183/13993003.01667-2019. [Epub ahead of print] No abstract available.

PMID:
31649066
4.

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

Burgel PR, Munck A, Durieu I, Chiron R, Mely L, Prevotat A, Murris-Espin M, Porzio M, Abely M, Reix P, Marguet C, Macey J, Sermet-Gaudelus I, Corvol H, Bui S, Lemonnier L, Dehillotte C, Da Silva J, Paillasseur JL, Hubert D; French Cystic Fibrosis Reference Network Study Group.

Am J Respir Crit Care Med. 2020 Jan 15;201(2):188-197. doi: 10.1164/rccm.201906-1227OC.

PMID:
31601120
5.

Do Cough and Sputum Production Predict COPD Exacerbations?: The Evidence Is Growing.

Martin C, Burgel PR.

Chest. 2019 Oct;156(4):641-642. doi: 10.1016/j.chest.2019.06.023. No abstract available.

PMID:
31590704
6.

The future of cystic fibrosis care: a global perspective.

Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-Hamblett N, Kashirskaya N, Kerem E, Mathew JL, McKone EF, Naehrlich L, Nasr SZ, Oates GR, O'Neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F.

Lancet Respir Med. 2020 Jan;8(1):65-124. doi: 10.1016/S2213-2600(19)30337-6. Epub 2019 Sep 27. Review. Erratum in: Lancet Respir Med. 2019 Dec;7(12):e40.

PMID:
31570318
7.

Relationship between gender and survival in a real-life cohort of patients with COPD.

Zysman M, Burgel PR, Court-Fortune I, Brinchault-Rabin G, Nesme-Meyer P, Surpas P, Deslée G, Perez T, Le Rouzic O, Jebrak G, Chanez P, Paillasseur JL, Caillaud D, Roche N; Initiatives BPCO scientific committee and investigators.

Respir Res. 2019 Aug 22;20(1):191. doi: 10.1186/s12931-019-1154-3.

8.

Are there specific clinical characteristics associated with physician's treatment choices in COPD?

Roche N, Antoniadis A, Hess D, Li PZ, Kelkel E, Leroy S, Pison C, Burgel PR, Aguilaniu B; COLIBRI COPD Research Group.

Respir Res. 2019 Aug 20;20(1):189. doi: 10.1186/s12931-019-1156-1.

9.

Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities.

Perez T, Deslée G, Burgel PR, Caillaud D, Le Rouzic O, Zysman M, Escamilla R, Jebrak G, Chanez P, Court-Fortune I, Brinchault-Rabin G, Nesme-Meyer P, Paillasseur JL, Roche N; Initiatives BPCO Scientific Committee.

Int J Chron Obstruct Pulmon Dis. 2019 Jul 2;14:1399-1410. doi: 10.2147/COPD.S188412. eCollection 2019.

10.

Randomized controlled trials of pharmacological treatments to prevent COPD exacerbations: applicability to real-life patients.

Pahus L, Burgel PR, Roche N, Paillasseur JL, Chanez P; Initiatives BPCO scientific committee.

BMC Pulm Med. 2019 Jul 12;19(1):127. doi: 10.1186/s12890-019-0882-y.

11.

Respiratory Medicine and Research: The new English-language journal of the Société de pneumologie de langue française!

Burgel PR, Montani D, Blanc FX, Pigearias B, Roche N.

Respir Med Res. 2019 May;75:A1-A2. doi: 10.1016/j.resmer.2019.06.001. No abstract available.

PMID:
31256850
12.

Prevalence and management of chronic breathlessness in COPD in a tertiary care center.

Carette H, Zysman M, Morelot-Panzini C, Perrin J, Gomez E, Guillaumot A, Burgel PR, Deslee G, Surpas P, Le Rouzic O, Perez T, Chaouat A, Roche N, Chabot F; Initiatives BPCO (bronchopneumopathie chronique obstructive) Scientific Committee and Investigators.

BMC Pulm Med. 2019 May 16;19(1):95. doi: 10.1186/s12890-019-0851-5.

13.

External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study.

Almagro P, Martínez-Camblor P, Miravitlles M, Rodríguez-Carballeira M, Navarro A, Lamprecht B, Ramirez-Garcia Luna AS, Kaiser B, Alfageme I, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Celli BR, Marin JM, Ter Riet G, Sobradillo P, Lange P, Garcia-Aymerich J, Anto JM, Turner AM, Han MK, Langhammer A, Sternberg A, Leivseth L, Bakke P, Johannessen A, Oga T, Cosío B, Ancochea J, Echazarreta A, Roche N, Burgel PR, Sin DD, Puhan MA, Soriano JB; 3CIA collaboration.

COPD. 2019 Feb;16(1):8-17. doi: 10.1080/15412555.2018.1484440. Epub 2019 Mar 14.

PMID:
30870059
14.

Constitutive signaling activity of a receptor-associated protein links fertilization with embryonic patterning in Arabidopsis thaliana.

Neu A, Eilbert E, Asseck LY, Slane D, Henschen A, Wang K, Bürgel P, Hildebrandt M, Musielak TJ, Kolb M, Lukowitz W, Grefen C, Bayer M.

Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5795-5804. doi: 10.1073/pnas.1815866116. Epub 2019 Mar 4.

15.

Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests.

Topalovic M, Das N, Burgel PR, Daenen M, Derom E, Haenebalcke C, Janssen R, Kerstjens HAM, Liistro G, Louis R, Ninane V, Pison C, Schlesser M, Vercauter P, Vogelmeier CF, Wouters E, Wynants J, Janssens W; Pulmonary Function Study Investigators; Pulmonary Function Study Investigators:.

Eur Respir J. 2019 Apr 11;53(4). pii: 1801660. doi: 10.1183/13993003.01660-2018. Print 2019 Apr.

PMID:
30765505
16.

Cumulative radiation dose after lung transplantation in patients with cystic fibrosis.

Fitton I, Revel MP, Burgel PR, Hernigou A, Boussaud V, Guillemain R, Le Pimpec-Barthes F, Bennani S, Freche G, Frija G, Chassagnon G.

Diagn Interv Imaging. 2019 May;100(5):287-294. doi: 10.1016/j.diii.2018.12.006. Epub 2019 Jan 30.

PMID:
30711497
17.

Reply to Polverino: Deconvoluting Chronic Obstructive Pulmonary Disease: Are B Cells the Frontrunners?

Ladjemi MZ, Burgel PR, Pilette C.

Am J Respir Crit Care Med. 2019 May 1;199(9):1171-1172. doi: 10.1164/rccm.201812-2249LE. No abstract available.

18.

Cluster and CART analyses identify large subgroups of adults with cystic fibrosis at low risk of 10-year death.

Burgel PR, Lemonnier L, Dehillotte C, Sykes J, Stanojevic S, Stephenson AL, Paillasseur JL.

Eur Respir J. 2019 Mar 14;53(3). pii: 1801943. doi: 10.1183/13993003.01943-2018. Print 2019 Mar.

PMID:
30578399
19.

Automated computed tomographic scoring of lung disease in adults with primary ciliary dyskinesia.

Hoang-Thi TN, Revel MP, Burgel PR, Bassinet L, Honoré I, Hua-Huy T, Martin C, Maitre B, Chassagnon G.

BMC Pulm Med. 2018 Dec 18;18(1):194. doi: 10.1186/s12890-018-0758-6.

20.

[Respiratory Medicine and Research: The new SPLF's anglophone journal].

Burgel PR, Montani D, Pigearias B, Blanc FX, Roche N.

Rev Pneumol Clin. 2018 Dec;74(6):367-368. doi: 10.1016/j.pneumo.2018.11.001. French. No abstract available.

PMID:
30527221
21.

Acute and chronic non-pulmonary complications in adults with cystic fibrosis.

Regard L, Martin C, Chassagnon G, Burgel PR.

Expert Rev Respir Med. 2019 Jan;13(1):23-38. doi: 10.1080/17476348.2019.1552832. Epub 2018 Nov 30. Review.

PMID:
30472915
22.

Validation of the French 3-year prognostic score using the Canadian Cystic Fibrosis registry.

Coriati A, Sykes J, Nkam L, Hocine MN, Burgel PR, Stephenson AL.

J Cyst Fibros. 2019 May;18(3):396-398. doi: 10.1016/j.jcf.2018.10.014. Epub 2018 Nov 3.

PMID:
30396836
23.

[Acute pulmonary and non-pulmonary complications in adults with cystic fibrosis].

Lafoeste H, Regard L, Martin C, Chassagnon G, Burgel PR.

Rev Pneumol Clin. 2018 Oct;74(5):267-278. doi: 10.1016/j.pneumo.2018.09.004. Epub 2018 Oct 19. Review. French.

PMID:
30343944
24.

Increased IgA Expression in Lung Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease.

Ladjemi MZ, Martin C, Lecocq M, Detry B, Nana FA, Moulin C, Weynand B, Fregimilicka C, Bouzin C, Thurion P, Carlier F, Serré J, Gayan-Ramirez G, Delos M, Ocak S, Burgel PR, Pilette C.

Am J Respir Crit Care Med. 2019 Mar 1;199(5):592-602. doi: 10.1164/rccm.201802-0352OC.

PMID:
30339768
25.

[Bronchiectasis in adults: Etiological diagnosis].

Martin C, Regard L, Chassagnon G, Burgel PR.

Rev Pneumol Clin. 2018 Oct;74(5):292-298. doi: 10.1016/j.pneumo.2018.09.011. Epub 2018 Oct 11. Review. French.

PMID:
30318255
26.

[Ageing with cystic fibrosis: Classical and emerging comorbidities in adults with cystic fibrosis].

Regard L, Lafoeste H, Martin C, Chassagnon G, Burgel PR.

Rev Pneumol Clin. 2018 Oct;74(5):279-291. doi: 10.1016/j.pneumo.2018.09.012. Epub 2018 Oct 11. Review. French.

PMID:
30316653
27.

[Personalised COPD care: Where are we going?]

Roche N, Martin C, Burgel PR.

Rev Pneumol Clin. 2018 Oct;74(5):315-326. doi: 10.1016/j.pneumo.2018.09.003. Epub 2018 Oct 11. Review. French.

PMID:
30316649
28.

Exploring the Role of Tertiary Lymphoid Structures Using a Mouse Model of Bacteria-Infected Lungs.

Teillaud JL, Regard L, Martin C, Sibéril S, Burgel PR.

Methods Mol Biol. 2018;1845:223-239. doi: 10.1007/978-1-4939-8709-2_13.

PMID:
30141016
29.

An attempt at modeling COPD epidemiological trends in France.

Burgel PR, Laurendeau C, Raherison C, Fuhrman C, Roche N.

Respir Res. 2018 Jun 27;19(1):130. doi: 10.1186/s12931-018-0827-7.

30.

An automated computed tomography score for the cystic fibrosis lung.

Chassagnon G, Martin C, Burgel PR, Hubert D, Fajac I, Paragios N, Zacharaki EI, Legmann P, Coste J, Revel MP.

Eur Radiol. 2018 Dec;28(12):5111-5120. doi: 10.1007/s00330-018-5516-x. Epub 2018 Jun 4.

PMID:
29869171
31.

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis.

De Rose V, Burgel PR, Gaggar A, Greene C.

Mediators Inflamm. 2018 May 2;2018:7280747. doi: 10.1155/2018/7280747. eCollection 2018. No abstract available.

32.

Cured bronchi! Extending the use of nebulised hypertonic saline outside of cystic fibrosis?

Martin C, Regard L, Burgel PR.

Eur Respir J. 2018 May 17;51(5). pii: 1800755. doi: 10.1183/13993003.00755-2018. Print 2018 May. No abstract available.

33.

A prospective analysis of unplanned patient-initiated contacts in an adult cystic fibrosis centre.

Burnet E, Hubert D, Champreux J, Honoré I, Kanaan R, Panzo R, Burgel PR.

J Cyst Fibros. 2018 Sep;17(5):636-642. doi: 10.1016/j.jcf.2018.04.006. Epub 2018 May 8.

PMID:
29748153
34.

Peribronchial tertiary lymphoid structures persist after rituximab therapy in patients with cystic fibrosis.

Regard L, Martin C, Zemoura L, Geolier V, Sage E, Burgel PR.

J Clin Pathol. 2018 Aug;71(8):752-753. doi: 10.1136/jclinpath-2018-205160. Epub 2018 Apr 27. No abstract available.

PMID:
29703760
35.

[Lower limit of normal vs. fixed ratio for the diagnosis of COPD: Is it that important?]

Burgel PR.

Rev Mal Respir. 2018 Mar;35(3):235-237. doi: 10.1016/j.rmr.2018.04.003. French. No abstract available.

PMID:
29699778
36.

Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.

Biton J, Ouakrim H, Dechartres A, Alifano M, Mansuet-Lupo A, Si H, Halpin R, Creasy T, Bantsimba-Malanda C, Arrondeau J, Goldwasser F, Boudou-Rouquette P, Fournel L, Roche N, Burgel PR, Goc J, Devi-Marulkar P, Germain C, Dieu-Nosjean MC, Cremer I, Herbst R, Damotte D.

Am J Respir Crit Care Med. 2018 Oct 1;198(7):928-940. doi: 10.1164/rccm.201706-1110OC.

PMID:
29518341
37.

Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease.

Guerra B, Haile SR, Lamprecht B, Ramírez AS, Martinez-Camblor P, Kaiser B, Alfageme I, Almagro P, Casanova C, Esteban-González C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Marin JM, Ter Riet G, Sobradillo P, Lange P, Garcia-Aymerich J, Antó JM, Turner AM, Han MK, Langhammer A, Leivseth L, Bakke P, Johannessen A, Oga T, Cosio B, Ancochea-Bermúdez J, Echazarreta A, Roche N, Burgel PR, Sin DD, Soriano JB, Puhan MA; 3CIA collaboration.

BMC Med. 2018 Mar 2;16(1):33. doi: 10.1186/s12916-018-1013-y.

38.

On Don Quixote and pink puffers: multi-organ loss of tissue COPD.

Soriano JB, Burgel PR.

Eur Respir J. 2018 Feb 7;51(2). pii: 1702560. doi: 10.1183/13993003.02560-2017. Print 2018 Feb. No abstract available.

39.

Blood eosinophil counts as a guide for COPD treatment strategies.

Roche N, Zysman M, Burgel PR.

Lancet Respir Med. 2018 Feb;6(2):78-80. doi: 10.1016/S2213-2600(18)30005-5. Epub 2018 Jan 10. No abstract available.

PMID:
29331310
40.

The Major Chromoblastomycosis Etiologic Agent Fonsecaea pedrosoi Activates the NLRP3 Inflammasome.

de Castro RJA, Siqueira IM, Jerônimo MS, Basso AMM, Veloso Junior PHH, Magalhães KG, Leonhardt LC, de Oliveira SAM, Bürgel PH, Tavares AH, Bocca AL.

Front Immunol. 2017 Nov 20;8:1572. doi: 10.3389/fimmu.2017.01572. eCollection 2017.

41.

A simple algorithm for the identification of clinical COPD phenotypes.

Burgel PR, Paillasseur JL, Janssens W, Piquet J, Ter Riet G, Garcia-Aymerich J, Cosio B, Bakke P, Puhan MA, Langhammer A, Alfageme I, Almagro P, Ancochea J, Celli BR, Casanova C, de-Torres JP, Decramer M, Echazarreta A, Esteban C, Gomez Punter RM, Han MK, Johannessen A, Kaiser B, Lamprecht B, Lange P, Leivseth L, Marin JM, Martin F, Martinez-Camblor P, Miravitlles M, Oga T, Sofia Ramírez A, Sin DD, Sobradillo P, Soler-Cataluña JJ, Turner AM, Verdu Rivera FJ, Soriano JB, Roche N; Initiatives BPCO, EABPCO, Leuven and 3CIA study groups.

Eur Respir J. 2017 Nov 2;50(5). pii: 1701034. doi: 10.1183/13993003.01034-2017. Print 2017 Nov.

42.

Staining and Clearing of Arabidopsis Reproductive Tissue for Imaging of Fluorescent Proteins.

Slane D, Bürgel P, Bayer M.

Methods Mol Biol. 2017;1669:87-94. doi: 10.1007/978-1-4939-7286-9_8.

PMID:
28936652
43.

A first step to STOP cystic fibrosis exacerbations.

Burgel PR, Reid DW, Aaron SD.

J Cyst Fibros. 2017 Sep;16(5):529-531. doi: 10.1016/j.jcf.2017.08.006. No abstract available.

44.

Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis.

Burgel PR, Bellis G, Elborn JS.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700763. doi: 10.1183/13993003.00763-2017. Print 2017 Aug. No abstract available.

45.

Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis.

Marteyn BS, Burgel PR, Meijer L, Witko-Sarsat V.

Front Cell Infect Microbiol. 2017 Jun 30;7:243. doi: 10.3389/fcimb.2017.00243. eCollection 2017. Review.

46.

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD.

Zysman M, Deslee G, Caillaud D, Chanez P, Escamilla R, Court-Fortune I, Nesme-Meyer P, Perez T, Paillasseur JL, Pinet C, Jebrak G, Roche N, Burgel PR.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 20;12:1819-1824. doi: 10.2147/COPD.S129787. eCollection 2017.

47.

Cystic fibrosis: Current aspects and perspectives.

Burgel PR, Fajac I.

Presse Med. 2017 Jun;46(6 Pt 2):e85-e86. doi: 10.1016/j.lpm.2017.06.001. French. No abstract available.

PMID:
28641709
48.

[Changing patterns of medication prescription for COPD patients in France. Impact of long-acting muscarinic antagonists' availability].

Jébrak G, Burgel PR, Caillaud D, Deslée G, Brinchault G, Chanez P, Court-Fortune I, Escamilla R, Nesme-Meyer P, Pinet C, Perez T, Paillasseur JL, Roche N; pour le groupe Initiatives BPCO.

Rev Mal Respir. 2017 May;34(5):535-543. doi: 10.1016/j.rmr.2017.02.006. Epub 2017 May 31. French.

PMID:
28578989
49.

The changing epidemiology and demography of cystic fibrosis.

Stephenson AL, Stanojevic S, Sykes J, Burgel PR.

Presse Med. 2017 Jun;46(6 Pt 2):e87-e95. doi: 10.1016/j.lpm.2017.04.012. Epub 2017 May 26.

PMID:
28554720
50.

Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Société de pneumologie de langue française (summary).

Jouneau S, Dres M, Guerder A, Bele N, Bellocq A, Bernady A, Berne G, Bourdin A, Brinchault G, Burgel PR, Carlier N, Chabot F, Chavaillon JM, Cittee J, Claessens YE, Delclaux B, Deslée G, Ferré A, Gacouin A, Girault C, Ghasarossian C, Gouilly P, Gut-Gobert C, Gonzalez-Bermejo J, Jebrak G, Le Guillou F, Léveiller G, Lorenzo A, Mal H, Molinari N, Morel H, Morel V, Noel F, Pégliasco H, Perotin JM, Piquet J, Pontier S, Rabbat A, Revest M, Reychler G, Stelianides S, Surpas P, Tattevin P, Roche N.

Rev Mal Respir. 2017 Apr;34(4):282-322. doi: 10.1016/j.rmr.2017.03.034. Epub 2017 May 25.

PMID:
28552256

Supplemental Content

Loading ...
Support Center